Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profiling,Psycho-Oncology

当前位置： X-MOL 学术 › Psycho-Oncology › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profiling
Psycho-Oncology ( IF 3.3 ) Pub Date : 2021-07-08 , DOI: 10.1002/pon.5764
Phyllis Butow ₁ , Fabiola Müller _{2,

3} , Christine E Napier ₄ , Nicci Bartley ₁ , Mandy L Ballinger _{4,

5} , Barbara Biesecker ₆ , Ilona Juraskova ₁ , Bettina Meiser ₇ , Timothy E Schlub ₈ , David M Thomas _{4,

5} , David Goldstein ₉ , Megan C Best _{1,

10} ,

Affiliation

School of Psychology, Psycho-Oncology Co-operative Research Group, The University of Sydney, Sydney, New South Wales, Australia.
Faculty of Science, School of Psychology, Quality of Life Office, The University of Sydney, Sydney, New South Wales, Australia.
Department of Medical Psychology, Amsterdam Public Health Research Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Cancer Theme, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
St Vincent's Clinical School, University of New South Wales, Darlinghurst, New South Wales, Australia.
RTI International, Washington, District of Columbia, USA.
Psychosocial Research Group, Prince of Wales Clinical School, University of New South Wales, Kensington, New South Wales, Australia.
Faculty of Medicine and Health, Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Department of Medical Oncology, Prince of Wales Hospital, Randwick, New South Wales, Australia.
Institute for Ethics and Society, University of Notre Dame, Broadway, New South Wales, Australia.

Fear of cancer progression (FCP) impacts quality of life and is a prevalent unmet need in patients diagnosed with advanced cancer, particularly as treatment options are reduced. We aimed to identify longitudinal patterns in FCP over 6 months in patients with advanced cancer receiving comprehensive tumour genomic profiling (CTGP) results, and their correlates.

中文翻译：

接受全面肿瘤基因组分析的罕见晚期癌症患者害怕癌症进展的纵向模式

对癌症进展的恐惧 (FCP) 会影响生活质量，并且是被诊断患有晚期癌症的患者普遍存在的未满足需求，尤其是在治疗选择减少的情况下。我们旨在确定接受综合肿瘤基因组分析 (CTGP) 结果的晚期癌症患者超过 6 个月的 FCP 纵向模式及其相关性。

更新日期：2021-07-08

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11